Error! You must have javascript enabled to use this form. Please enable Javascript in your browser. NASDAQ:XERS Shareholder Notice: Investigation over Potential Wrongdoing at Xeris Pharmaceuticals, Inc. Certain directors of Xeris Pharmaceuticals, Inc. are under investigation over potential breaches of fiduciary duties. View full press release Your Name: Your Email: To Email: To BCC: Subject: Comments: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send